PTGS2 and neoplasm: Pre-dosing of HCA-7 tumor-bearing mice with 2 mg of celecoxib per mouse resulted in a 16 % decrease of radioactivity uptake in the tumor at 60 min p.i., while the remaining ~80 % may be related to non-specific and non-COX-2-mediated interactions.